TURMETAB LAUNCHES IN THE PHILIPPINES   

- Advertisement (970x250 Desktop) -

- Advertisement (300x250) -

PAGEONE Spotlight

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry


Turmetab, the country’s first FDA-approved supplement that combines turmeric and piperine to combat stress, launched today in the Philippines. Turmetab offers whole turmeric roots in easy-to-take tablets, aiming to give Filipinos the vitality and nutrition they need to combat a range of ailments and stay at their physical and mental best.




Benefits of taking turmeric with piperine include:

· Supports joint and muscle health;

- Advertisement (300x250) -

· Helps target multiple inflammatory diseases, including arthritis;

· Boosts brain health; and

· Overall anti-inflammatory and anti-oxidant support.

Distributed by Distribution Solutions Philippines, Inc. (‘Distriphil’), a National Company committed to setting New Standards and Excellent Service in Healthcare Solution, with the ultimate goal of providing care and improving health. Turmetab is already available in Mercury Drugstore and South Star Drug.

Cor-Marie Bacdayan, Group Product Manager said: “Medical research have shown us the health benefits of turmeric, and we are proud to bring Turmetab to Filipinos, nationwide. The ability to do one’s best starts with one’s physical and mental health, and we are committed in helping Filipinos defy limitations.”

For more information, visit www.facebook.com/Turmetab

###

ABOUT DISTRIBUTION SOLUTIONS PHILIPPINES, INC. (DISTRIPHIL)

Distribution Solutions Philippines, Inc. (Distriphil) is involved in the nationwide marketing, sales, and distribution of ethical and over-the-counter products for its own In-house brands as well as the brands of partner companies.

Distriphil is the newest subsidiary of the Chiongbian Group of Companies registered as a company in July 2013. It has three (3) divisions, namely: the Primary Care, Vaccines and Oncology divisions.

For more information, visit www.distriphil.com

This article has been initially published last

What can you say about this story?

- Advertisement (300x250) -

What's the latest?

- Advertisement (970 x 250 Desktop) -